Dificid fidaxomicin regulatory update

The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) published new guidelines recommending fidaxomicin for Clostridium difficile infection

Read the full 197 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE